Epicutaneous immunotherapy for peanut allergy modifies IgG 4 responses to major peanut allergens.

Stef J Koppelman,Aurélie Peillon, Wenceslas Agbotounou,Hugh A Sampson,Laurent Martin

Journal of Allergy and Clinical Immunology（2019）

引用 11|浏览4

暂无评分

摘要

Epicutaneous immunotherapy (EPIT) for peanut allergy is an investigational therapy currently in development. This study shows that EPIT induces IgG to the major peanut allergens, Ara h 1, h 2, h 3 and h 6.

查看译文

关键词

Allergens,Allergy,IgG(4),Immunotherapy,Peanut

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要